Skip to Main Content
TABLE 9.2

Medications for Lowering Glucose, Summary of Characteristics

Medications for Lowering Glucose, Summary of Characteristics
Medications for Lowering Glucose, Summary of Characteristics

*For agent-specific dosing recommendations, please refer to manufacturers’ prescribing information. 1Tsapas A, Avgerinos I, Karagiannis T, et al. Ann Intern Med 2020;173:278–286. 2Tsapas A, Karagiannis T, Kakotrichi P, et al. Diabetes Obes Metab 2021;23:2116–2124. CVOT, cardiovascular outcomes trial; GIP, gastric inhibitory polypeptide; GLP-1 RA, glucagon-like peptide 1 receptor agonist; NASH, nonalcoholic steatohepatitis; SQ, subcutaneous; T2DM, type 2 diabetes mellitus. Reprinted from Davies MJ, Aroda VR, Collins BS, et al. Diabetes Care 2022;45:2753–2786.

Close Modal

or Create an Account

Close Modal
Close Modal